Angiotensinkonvertierendes Enzym 2 (ACE2): Rolle in der Pathogenese von Erkrankungen außerhalb von COVID-19

Patel VB et al (2016) Role of the ACE2/Angiotensin 1–7 axis of the Renin-Angiotensin system in heart failure. Circ Res 118(8):1313–1326

Tipnis SR et al (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275(43):33238–33243

Donoghue M et al (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res 87(5):E1–E9

Santos RAS et al (2018) The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7). Physiol Rev 98(1):505–553

Imai Y et al (2010) Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. Circ J 74(3):405–410

Hrenak J, Simko F (2020) Renin-Angiotensin system: an important player in the pathogenesis of acute respiratory distress syndrome. Int J Mol Sci. https://doi.org/10.3390/ijms21218038

Chatterjee P et al (2020) Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications. Clin Sci 134(17):2319–2336

Mizuiri S, Ohashi Y (2015) ACE and ACE2 in kidney disease. World J Nephrol 4(1):74–82

Yusuf S et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358(15):1547–1559

Marquez A et al (2021) An update on ACE2 amplification and its therapeutic potential. Acta Physiol 231(1):e13513